Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting
Top Cited Papers
- 20 July 2007
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (21), 3168-3173
- https://doi.org/10.1200/jco.2006.08.2313
Abstract
Intravascular large B-cell lymphoma (IVLBCL) is a rare form of diffuse LBCL characterized by preferential intravascular growth of malignant lymphocytes, aggressive behavior, and an often fatal course. IVLBCL usually affects elderly patients with poor performance status, elevated lactic dehydrogenase serum levels, anemia, and B symptoms. It displays some differences in clinical presentation among diverse geographical areas, mostly between patients diagnosed in Western countries and Japan. In addition, data from the literature suggest that pathologic diagnostic criteria as well as clinical features of this disease may be broader than described in current classification scheme(s). Under the sponsorship of the International Extranodal Lymphoma Study Group, clinicians and pathologists with interest in IVLBCL, coming from Western and Eastern countries, joined to reach a consensus on defining features as well as to focus on the most urgent unresolved issues in IVLBCL. To this end, a representative group of IVLBCL patients coming from both the aforementioned geographical areas were collectively analyzed. Additional features of IVLBCL were proposed both under clinical and pathologic stand points. At the meeting, it emerged that IVLBCL may have additional histopathologic/cytologic definition criteria with respect to those currently recommended, some clinical features are not randomly distributed worldwide, recent therapeutic approaches, such as anti-CD20–containing regimens, may improve outcome, and kidney, spleen, and liver involvement may show peculiar histopathologic features. Finally, a provisional practical diagnostic approach to hemophagocytosis-associated patients and a proposal for the most useful criteria in the settings of differential diagnosis are included.Keywords
This publication has 31 references indexed in Scilit:
- Intravascular lymphoma: a role for single-agent rituximabLeukemia & Lymphoma, 2006
- Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two casesLaboratory Investigation, 2005
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004
- Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaAnnals of Oncology, 2004
- Angiotropic Lymphoma: An Immunophenotypically and Clinically Heterogeneous LymphomaLaboratory Investigation, 2001
- Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 2001
- Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosisBone Marrow Transplantation, 2001
- An Asian variant of intravascular large B‐cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B‐cell lymphoma associated with haemophagocytic syndromeBritish Journal of Haematology, 2000
- Haemophagocytic syndrome associated with infectionsBest Practice & Research Clinical Haematology, 2000
- SUCCESSFUL AUTOLOGOUS BONE MARROW TRANSPLANTATION IN INTRAVASCULAR LYMPHOMATOSISBritish Journal of Haematology, 1999